The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Nature

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/312763A0PMID 6096719
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The acquired immune deficiency syndrome.

  1984cited by this paper
• Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy.

  1984cited by this paper
• Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines.

  1984cited by this paper
• T-lymphocyte T4 molecule behaves as the receptor for human retrovirus  LAV

  1984cited by this paper
• Pseudotypes of human T-cell leukemia virus types 1 and 2: neutralization by patients' sera.

  1984cited by this paper
• Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses.

  1984cited by this paper
• Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

  1984cited by this paper
• Isolation of new lymphotropic retrovirus from two siblings with haemophilia B, one with AIDS.

  1984cited by this paper
• Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.

  1984cited by this paper
• Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.

  1984cited by this paper
• Detection of IgG antibodies to lymphadenopathy-associated virus in patients with AIDS or lymphadenopathy syndrome.

  1984cited by this paper
• Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.

  1984cited by this paper
• Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.

  1984cited by this paper
• Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS.

  1984cited by this paper
• Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

  1984cited by this paper
• Human T-cell leukemia-lymphoma virus (HTLV).

  1983cited by this paper
• Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage.

  1983cited by this paper
• Productive infection and cell-free transmission of human T-cell leukemia virus in a nonlymphoid cell line.

  1983cited by this paper
• Detection of lymphocytes producing a human retrovirus associated with adult T-cell leukemia by syncytia induction assay.

  1983cited by this paper
• Human T-cell leukemia virus type II transforms normal human lymphocytes.

  1983cited by this paper
• Human T‐cell leukemia virus type I: Induction of syncytia and inhibition by patients' sera

  1983cited by this paper
• Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte-conditioned medium: detection of T4 antigen and its presence on normal blood monocytes.

  1983cited by this paper
• Cell receptors for baboon endogenous virus recognized by monoclonal antibodies

  1983cited by this paper
• Transformation of human umbilical cord blood T cells by human T-cell leukemia/lymphoma virus.

  1983cited by this paper
• Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

  1983cited by this paper
• Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions.

  1982cited by this paper
• Is the acetylcholine receptor a rabies virus receptor?

  1982cited by this paper
• Dissection of immunoregulatory subpopulations of T lymphocytes within the helper and suppressor sublineages in man.

  1982cited by this paper
• Biochemical analysis of human T lymphocyte differentiation antigens T4 and T5.

  1980cited by this paper
• Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)

  1976cited by this paper
• Virus envelope markers in mammalian tropism of avian RNA tumor viruses

  1975cited by this paper
• Pseudotypes of vesicular stomatitis virus with the coat of murine leukaemia and of avian myeloblastosis viruses.

  1972cited by this paper

• B Cell Receptor’s function in virus entry: Anti-SARS-CoV-2 B cell receptors can mediate viral entry in an ACE2-independent mechanism

  2026cites this paper
• Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection

  2026cites this paper
• Radiopharmaceuticals and their applications in medicine

  2025cites this paper
• Modeling the Interplay Between Viral and Immune Dynamics in HIV: A Review and Mrgsolve Implementation and Exploration

  2025cites this paper
• Stoichiometry of HIV-1 envelope glycoprotein protomers with changes that stabilize or destabilize the pretriggered conformation

  2025cites this paper
• Antibody-Drug Conjugates Using CD4 Mimics and a Neutralizing Antibody as HIV-1 Entry Inhibitors.

  2025cites this paper
• Integrative Computational Approaches for Understanding Drug Resistance in HIV-1 Protease Subtype C

  2025cites this paper
• mGem: The complexity of viral entry—one virus, many receptors

  2025cites this paper
• Single-cell delineation of strain-specific HIV-1 Vif activities using dual reporter sensor cells and live cell imaging

  2025cites this paper
• Soluble CD4 inhibits Ebola virus infection by targeting endosomal receptor-binding site.

  2025cites this paper
• COVID-19 and HIV—Interaction, clinical course, outcome, and prognosis

  2025cites this paper
• The Role of AZT (Azidothymidine) in the Treatment of HIV and AIDS

  2025cites this paper
• New Insights into HIV Life Cycle, Th1/Th2 Shift during HIV Infection and Preferential Virus Infection of Th2 Cells: Implications of Early HIV Treatment Initiation and Care

  2024cites this paper
• The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity

  2024cites this paper
• Current status of the small molecule anti-HIV drugs in the pipeline or recently approved.

  2024cites this paper
• The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity

  2024cites this paper
• AI-based IsAb2.0 for antibody design

  2024cites this paper
• Membrane HIV-1 envelope glycoproteins stabilized more strongly in a pretriggered conformation than natural virus Envs

  2024cites this paper
• A Step Towards Optimization of Amide-Linked Coumarin Pharmacophore: As an Anti-HIV Agent.

  2024cites this paper
• Host RNA-Binding Proteins as Regulators of HIV-1 Replication

  2024cites this paper
• Characterization of a CXCR4 antagonist TIQ-15 with dual tropic HIV entry inhibition properties

  2024cites this paper
• Development of HIV-1 vectors pseudotyped with envelope proteins of other retroviruses.

  2024cites this paper
• Helper T cell immunity in humans with inherited CD4 deficiency

  2024cites this paper
• Nicholas Avrion Mitchison. 5 May 1928 — 28 December 2022

  2024cites this paper
• Stoichiometry of HIV-1 Envelope Glycoprotein Protomers with Changes That Stabilize or Destabilize the Pretriggered Conformation

  2024cites this paper
• Bioorthogonal click labeling of an amber-free HIV-1 provirus for in-virus single molecule imaging.

  2024cites this paper
• Nicotine is an Immunosuppressant: Implications for Women's Health and Disease.

  2024cites this paper
• Four Decades of HIV: Global Trends, Testing Assays, Treatment, and Challenges

  2024cites this paper
• Significance of Artificial Intelligence in the Study of Virus–Host Cell Interactions

  2024cites this paper
• The V2 domain of HIV gp120 mimics an interaction between CD4 and integrin ⍺4β7

  2023cites this paper
• Progress in Pathological and Therapeutic Research of HIV-Related Neuropathic Pain

  2023cites this paper
• HIV reservoirs are dominated by genetically younger and clonally enriched proviruses

  2023cites this paper
• Evolution Driven By A Varying Host Environment Selects For Distinct HIV-1 Entry Phenotypes and Other Informative Variants.

  2023cites this paper
• Phytochemicals and HIV Suppression: A Systematic Review

  2023cites this paper
• Insights into product and process related challenges of lentiviral vector bioprocessing

  2023cites this paper
• Therapeutically targeting the consequences of HIV-1-associated gastrointestinal dysbiosis: Implications for neurocognitive and affective alterations.

  2023cites this paper
• Malignant Melanoma in a Retrospective Cohort of Immunocompromised Patients: A Statistical and Pathologic Analysis

  2023cites this paper
• Emerging role of cyclophilin A in HIV-1 infection: from producer cell to the target cell nucleus

  2023cites this paper
• An intact amber-free HIV-1 system for in-virus protein bioorthogonal click labeling that delineates envelope conformational dynamics

  2023cites this paper
• HIV/Mtb Co-Infection: From the Amplification of Disease Pathogenesis to an “Emerging Syndemic”

  2023cites this paper
• Assays Based on Pseudotyped Viruses.

  2023cites this paper
• Development of animal models for emerging infectious diseases by breaking the barrier of species susceptibility to human pathogens

  2023cites this paper
• HIV reservoirs are dominated by genetically younger and clonally enriched proviruses

  2023cites this paper
• Entry receptors — the gateway to alphavirus infection

  2023cites this paper
• Inhibition of human immunodeficiency virus (HIV-1) infectivity by expression of poorly or broadly neutralizing antibodies against Env in virus-producing cells

  2023cites this paper
• HIV-1 capsid and viral DNA integration

  2023cites this paper
• Cell-to-Cell Transmission of HIV-1 and HIV-2 from Infected Macrophages and Dendritic Cells to CD4+ T Lymphocytes

  2023cites this paper
• Multivalent sialic acid materials for biomedical applications.

  2023cites this paper
• V3 tip determinants of susceptibility to inhibition by CD4-mimetic compounds in natural clade A human immunodeficiency virus (HIV-1) envelope glycoproteins

  2023cites this paper
• Active targeting of CD4+ T lymphocytes by PEI-capped, peptide-functionalized gold nanoparticles

  2022cites this paper
• Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression

  2022cites this paper
• Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity

  2022cites this paper
• Nanomedicines encountering HIV dementia: A guiding star for neurotherapeutics

  2022cites this paper
• Understanding Retroviral Life Cycle and its Genomic RNA Packaging.

  2022cites this paper
• Net charge and position 22 of the V3 loop are associated with HIV-1 tropism in recently infected female sex workers in Nairobi, Kenya

  2022cites this paper
• Synthetic Mucin Gels with Self‐Healing Properties Augment Lubricity and Inhibit HIV‐1 and HSV‐2 Transmission

  2022cites this paper
• Role of RNA Polymerase II Promoter-Proximal Pausing in Viral Transcription

  2022cites this paper
• IMMUNOMETABOLIC REPROGRAMMING DURING SUPPRESSIVE HIV-1 INFECTION

  2022cites this paper
• HIV skews the SARS-CoV-2 B cell response towards an extrafollicular maturation pathway

  2022cites this paper
• Structure-Based Stabilization of SOSIP Env Enhances Recombinant Ectodomain Durability and Yield

  2022cites this paper
• Fusion Proteins CLD and CLDmut Demonstrate Potent and Broad Neutralizing Activity against HIV-1

  2022cites this paper
• Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound

  2022cites this paper
• Application of CRISPR/Cas Genomic Editing Tools for HIV Therapy: Toward Precise Modifications and Multilevel Protection

  2022cites this paper
• The Characteristics of the HIV-1 Env Glycoprotein Are Linked With Viral Pathogenesis

  2022cites this paper
• Nectin-2 Acts as a Viral Entry Mediated Molecule That Binds to Human Herpesvirus 6B Glycoprotein B

  2022cites this paper
• Therapeutic Metabolic Reprograming Using microRNAs: From Cancer to HIV Infection

  2022cites this paper
• State of the Art in Smart Portable, Wearable, Ingestible and Implantable Devices for Health Status Monitoring and Disease Management

  2022cites this paper
• Well Put Together—A Guide to Accessorizing with the Herpesvirus gH/gL Complexes

  2022cites this paper
• Pseudotyped lentiviral vectors: Ready for translation into targeted cancer gene therapy?

  2022cites this paper
• Global Increases in Human Immunodeficiency Virus Neutralization Sensitivity Due to Alterations in the Membrane-Proximal External Region of the Envelope Glycoprotein Can Be Minimized by Distant State 1-Stabilizing Changes

  2021cites this paper
• Studies on the prevalence of HIV/AIDS in Bangladesh including other developing countries

  2021influential citation
• A Simple and Reliable Reporter Assay to Test siRNA - Mediated Silencing of HIV - 1 Gene Functions

  2021cites this paper
• Prestimulation of CD2 confers resistance to HIV-1 latent infection in blood resting CD4 T cells

  2021cites this paper
• HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection wave

  2021cites this paper
• Nuclear Hormone Receptors and Host-Virus Interactions

  2021cites this paper
• Potential role of micro ribonucleic acids in screening for anal cancer in human papilloma virus and human immunodeficiency virus related malignancies

  2021cites this paper
• Reduction of Progranulin-Induced Breast Cancer Stem Cell Propagation by Sortilin-Targeting Cyclotriazadisulfonamide (CADA) Compounds.

  2021cites this paper
• The Hitchhiker Guide to CD4+ T-Cell Depletion in Lentiviral Infection. A Critical Review of the Dynamics of the CD4+ T Cells in SIV and HIV Infection

  2021cites this paper
• HIV status alters disease severity and immune cell responses in β variant SARS-CoV-2 infection wave

  2021cites this paper
• Optimisation of a TALE nuclease targeting the HIV co-receptor CCR5 for clinical application

  2021cites this paper
• The Interplay of HIV and Autophagy in Early Infection

  2021cites this paper
• Circumcision as an Intervening Strategy against HIV Acquisition in the Male Genital Tract

  2021cites this paper
• Novel Bent Conformation of CD4 Induced by HIV-1 Inhibitor Indirectly Prevents Productive Viral Attachment.

  2021cites this paper
• The characteristics of the HIV-1 Env glycoprotein contribute to viral pathogenesis

  2021cites this paper
• Asymmetric Structures and Conformational Plasticity of the Uncleaved Full-Length Human Immunodeficiency Virus Envelope Glycoprotein Trimer

  2021cites this paper
• Discovery of candidate HIV-1 latency biomarkers using an OMICs approach.

  2021cites this paper
• Identification of regulatory networks associated with anti-HIV/AIDS genes via integrated transcriptome, epigenome and proteome analyses

  2021cites this paper
• High Level Stable Expression of Recombinant HIV gp120 in Glutamine Synthetase Gene Deficient HEK293T Cells.

  2021cites this paper
• Mitochondrial changes associated with viral infectious diseases in the paediatric population

  2021cites this paper
• Simultaneous inhibition of human CD4 and 4-1BB biogenesis suppresses cytotoxic T lymphocyte proliferation

  2021cites this paper
• Small Molecule Cyclotriazadisulfonamide Abrogates the Upregulation of the Human Receptors CD4 and 4-1BB and Suppresses In Vitro Activation and Proliferation of T Lymphocytes

  2021cites this paper
• Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation

  2021cites this paper
• Increased Efficiency for Biallelic Mutations of the CCR5 Gene by CRISPR-Cas9 Using Multiple Guide RNAs As a Novel Therapeutic Option for Human Immunodeficiency Virus

  2021cites this paper
• Sec24C is an HIV-1 host dependency factor crucial for virus replication

  2021cites this paper
• Nucleic acid analysis on paper substrates (NAAPs): an innovative tool for Point of Care (POC) infectious disease diagnosis.

  2021cites this paper
• A tool with many applications: vesicular stomatitis virus in research and medicine

  2020cites this paper
• IGF1R is an entry receptor for respiratory syncytial virus

  2020cites this paper
• Broadly Neutralizing Antibodies to Highly Antigenically Variable Viruses as Templates for Vaccine Design.

  2020cites this paper
• Defining rules governing recognition and Fc-mediated effector functions to the HIV-1 co-receptor binding site

  2020cites this paper
• Efficient functional screening of a cellular cDNA library to identify severe fever with thrombocytopenia syndrome virus entry factors

  2020cites this paper